impact of second-line approval of liposomal irinotecan
Published 6 years ago • 1K plays • Length 3:54Download video MP4
Download video MP3
Similar videos
-
4:48
liposomal irinotecan in advanced pancreatic cancer
-
8:07
phase 1/2 study results of liposomal irinotecan and folfox in pancreatic cancer
-
4:22
mm-398 for second-line therapy in advanced pancreatic cancer
-
6:47
pancreatic cancer: data with liposomal irinotecan/5-fu
-
3:27
second-line pancreatic cancer: nanoliposomal irinotecan
-
1:29
dr. ocean on the development of nanoliposomal irinotecan in metastatic pancreatic cancer
-
1:41
dr. kundranda on efficacy of liposomal irinotecan in pancreatic cancer
-
7:24
pancreas cancer: incorporating nanoliposomal irinotecan
-
4:24
nifty: liposomal irinotecan in combination with 5fu and leucovorin in patients with mbtc
-
3:31
second-line decision-making in pancreatic cancer
-
5:03
sequencing decisions in advanced pancreatic cancer
-
38:24
current and future directions in metastatic pancreatic cancer
-
2:16
efficacy of nanoliposomal irinotecan in biliary tract cancer
-
1:43
liposomal irinotecan fluorouracil/leucovorin after progression in mpdac
-
0:55
robin brenner on side effects of onivyde for pancreatic cancer
-
12:20
dr. borgos, new frontiers in characterizations: the example of liposomal irinotecan nanomedicine
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
4:36
phase i/ii results: first-line nalirifox in patients with pancreatic ductal adenocarcinoma